However, peer-reviewed published pharmacoeconomic evaluations have generally found that GLP-1RA, specifically exenatide BID and exenatide weekly, are cost-effective when used as second-line treatment relative to analog basal insulins with costs per quality-adjusted life year within the generally accepted range for cost-effectiveness (Table 3)
Not logging your rotation
EPS guide of $8.65-$8.85/sh may not change meaningfully as LLY could opt to re-invest in upcoming launches in [Alzheimer's disease] and immunology," analyst Mohit Bansal wrote in a research note explaining the forecast
Since the introduction of Novo Nordisks semaglutide (Ozempic/Wegovy) and then Eli Lillys tirzepatide (Mounjaro/Zepbound), both companies have locked horns with US compounding pharmacies and wellness clinics that have produced their own versions of the drugs to corner a slice of this lucrative market
Lifestyle Factors Peptides won't out-perform bad habits
My work, to model for other women that there are many paths to self-acceptance, and none of them require suffering